Facet Wealth Inc. Purchases 37 Shares of HCA Healthcare, Inc. $HCA

Facet Wealth Inc. lifted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 6.1% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 643 shares of the company’s stock after buying an additional 37 shares during the quarter. Facet Wealth Inc.’s holdings in HCA Healthcare were worth $228,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of HCA. ORG Partners LLC raised its position in HCA Healthcare by 27.9% in the 2nd quarter. ORG Partners LLC now owns 142 shares of the company’s stock worth $55,000 after purchasing an additional 31 shares during the last quarter. Avantax Advisory Services Inc. raised its holdings in HCA Healthcare by 0.4% during the 1st quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company’s stock worth $2,791,000 after purchasing an additional 32 shares during the last quarter. Glenview Trust co raised its holdings in HCA Healthcare by 2.3% during the 1st quarter. Glenview Trust co now owns 1,451 shares of the company’s stock worth $501,000 after purchasing an additional 32 shares during the last quarter. Horizon Investments LLC raised its stake in shares of HCA Healthcare by 1.1% during the first quarter. Horizon Investments LLC now owns 3,175 shares of the company’s stock worth $1,097,000 after buying an additional 33 shares during the last quarter. Finally, Sivia Capital Partners LLC raised its stake in shares of HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after buying an additional 33 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently issued reports on HCA. Barclays increased their target price on HCA Healthcare from $445.00 to $494.00 and gave the stock an “overweight” rating in a research note on Monday. Cowen reaffirmed a “buy” rating on shares of HCA Healthcare in a research note on Monday. Morgan Stanley set a $425.00 target price on shares of HCA Healthcare in a research report on Monday. JPMorgan Chase & Co. raised their price objective on HCA Healthcare from $360.00 to $370.00 and gave the company a “neutral” rating in a report on Monday, August 4th. Finally, Stephens raised their price target on HCA Healthcare from $450.00 to $500.00 and gave the company an “overweight” rating in a research note on Monday. Thirteen analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $471.42.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $468.68 on Tuesday. The stock has a market cap of $109.67 billion, a PE ratio of 18.12, a PEG ratio of 1.41 and a beta of 1.40. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $469.18. The firm has a 50-day moving average of $416.33 and a 200-day moving average of $383.23.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. During the same period in the prior year, the company posted $4.90 EPS. The company’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio is presently 11.13%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.